Trials / Completed
CompletedNCT00116584
Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients
The Use of Heliox Driven Racemic Epinephrine Nebulization in the Treatment of Moderate to Severe Bronchiolitis in Pediatric Emergency Department Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 2 Months – 12 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess whether children with moderate to severe bronchiolitis treated with standard racemic epinephrine therapy via 70:30 helium-oxygen (heliox) driven nebulization will have improvements in measurements of airway more rapidly than those treated with conventional air-oxygen driven nebulization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | heliox | continuous heliox therapy |
| DRUG | oxygen | continuous oxygen therapy |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2008-03-01
- Completion
- 2011-10-01
- First posted
- 2005-06-30
- Last updated
- 2020-05-20
- Results posted
- 2020-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00116584. Inclusion in this directory is not an endorsement.